An Italian cancer research foundation in Trento, founded by the surgeon Alessio Pezcoller, that with the AACR gives a yearly international award for extraordinary achievement in cancer research, as well as grants and other prizes.
The Pezcoller Foundation in Trento was founded by Professor Alessio Pezcoller and has given prizes to researchers since 1988 and scholarships since 2006. Its best-known prize is the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research, worth 75,000 euros, created with the American Association for Cancer Research under an agreement signed in 1997 and renewed in 2018. The AACR describes it as recognising a scientist who has made a major discovery in basic cancer research or significant contributions to translational research and who is still active; Nobel laureates are not eligible. The winner lectures at the AACR Annual Meeting and at the Universities of Padua and Trento before the ceremony in Trento.
It replaced the Premio Internazionale Pezcoller, given to V. De Vita in 1988, M. Tubiana in 1991, Bert Vogelstein in 1993 and Paul Nurse in 1995. Winners of the joint award since 1998 include James P. Allison (2015), John E. Dick (2020), Steven A. Rosenberg (2022), Tak W. Mak (2023), Titia de Lange (2024) and Douglas Hanahan (2025). The foundation also gives, with the European Association for Cancer Research, a Translational Cancer Researcher Award, a Women in Cancer Research Award and a Rising Star Award.
Discovered that blocking CTLA-4 unleashes T cells against cancer, the work behind ipilimumab and the 2018 Nobel Prize.
Discovered cancer stem cells, showing leukaemia is driven by a rare population of self-renewing cells.
Father of cancer immunotherapy: first to cure patients with IL-2 and with their own tumour-infiltrating lymphocytes.
Cloned the T-cell receptor and co-discovered CTLA-4's brake function, foundations of modern immunotherapy.
Bert Vogelstein is the most-cited scientist in cancer genetics: he mapped how colorectal cancer develops and founded the field of cancer genome sequencing and blood-based detection.
Nobel laureate who discovered how cyclin-dependent kinases control cell division, and founding director of the Crick.
Shares Tak W. Mak, Steven A. Rosenberg, James P. Allison.
Shares King Faisal Foundation, Charles Rodolphe Brupbacher Foundation, American Association for Cancer Research (AACR).
Shares King Faisal Foundation, Lasker Foundation, American Association for Cancer Research (AACR).
Shares King Faisal Foundation, American Association for Cancer Research (AACR).
Shares Charles Rodolphe Brupbacher Foundation, American Association for Cancer Research (AACR).
Shares Tak W. Mak, Steven A. Rosenberg, James P. Allison.
Shares Lasker Foundation, American Association for Cancer Research (AACR).
Shares Lasker Foundation, American Association for Cancer Research (AACR).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/